[صفحه اصلی ]   [Archive]  
بخش‌های اصلی
صفحه اصلی::
اطلاعات مجله::
ثبت نام ::
آرشیو مقالات::
برای نویسندگان::
راهنمای داوران::
تماس با ما::
::
نمایه های مجله طب نظامی

Scopus

NLM Cataloge

CAB Abstracts and Global Health

ISC

Index Copernicus

Research Bible

SID

Magiran

Google Scholar 

جستجو در پایگاه

جستجوی پیشرفته
دریافت اطلاعات پایگاه
نشانی پست الکترونیک خود را برای دریافت اطلاعات و اخبار پایگاه، در کادر زیر وارد کنید.
:: دکتر سید مؤید علویان ::

CORRICULUM VITAE

Name: Seyed-Moayed Alavian
Nationality: Iranian
Specialty: Medical Internist
Subspecialty: Gastroenterologist
Address: Department of Internal Medicine, Baghiyatollah University of Medical Science, Mollasadra ave, Tehran, Iran.  Tehran Hepatitis Center
Contact:

Education and Qualifications
1982-1989: General Physician (MD) degree from School of Medicine, Tehran University of Medical Science
1989-1992: Resident in Internal Medicine, Tehran University of Medical Science
1992-1996: Clinical and Research Fellow, Gastroenterology and Hepatology, Gastroenterology Department Tehran University of Medical Science

Postgraduate activities
Work Shop In Advanced ERCP Sponsered  By Olympus Company, Tehran ,Iran 1992
Work Shop On Endosonography Sponsered By Olympus Company, Tehran,Iran 1999
Work Shop On Endosonography Sponsered By Olympus Company,Shiraz ,Iran 1999

Administrative Positions:
1992-2002: Assistant Professor of Medicine, Department of Internal Medicine, Baqiatollah University of Medical Science, Tehran, Iran
1996-1998: Chairman of the Department of Internal Medicine, Baqiatollah University of Medical Science, Tehran, Iran
1996 up to present: Head of Hepatitis Clinic, Iranian Blood Transfusion Organization (IBTO)
1998-2001: Chairman, Iranian Liver Charity
1998-2003: Dean of Baqiatollah University of Medical Science, Tehran, Iran
1998 up to now: Head of Tehran Hepatitis Center (THC)
2002 up to present: Associate Professor of Medicine, Department of Internal Medicine, Baqiatollah University of Medical Science, Tehran, Iran
2002 up to present: Counselor of the Iranian board of disease management, Ministry of Health and Medical Education
2002 up tp present: Vice Counselor, Committee of gastrointestinal disease, forensic medicine organization, IRI
2002 up to present: Counselor of Iranian Society of Physicians


Professional Organizations
1998 up to present: Iranian Liver Charity
1998 up to present: Tehran Hepatitis Center, Iran

Appointments:
1998: Founder of Iranian Liver Charity
1998: Founder of Tehran Hepatitis Center

Honors:
2001: Distinguished professor of Medicine, Baqiatollah University of Medical Science.
2002: Distinguished Researcher, Baqiatollah University of Medical Science.
1998: Honored article, International congress on geographical medicine, Shiraz, Iran
2002: Honored article and presenter, Seminar of 'Bench to bed on gastrointestinal disease', Tehran, Iran

 
Editorial Boards:
2002 up to present: Member of scientific committee: Digestive Disease Digest (DDD) Journal, Research Center for gastroenterology and Liver disease, Shaheed Beheshti University of Medical Science.
2001 up to present: Member of the Board of Editorial Consultants, Novin Journal of medicine.

Supervision Dissertations:
1-Risk Factors Of Hbv In Blood Donors. Thesis As A Partial Fulfillment For degree Of MD ,     By Ghassemian M.Advised By Alavian Sm,Tehran,Iran 1995
2-Prevalence of HBV in spouces of hbv carrier.Thesis As A Partial Fulfillment For Specialty board of Internal Medicine ,By Farnodi HM. Advised By Alavian SM, Tehran, Iran 1996
3-Clinical manifestion ,causes, and coplication of Liver Cirrhosis in Shariati hospital.Thesis As Partial Fulfillment For degree of MD , By Alavi M. Advised By Alavian SM,Tehran,Iran
4-     Risk Factors Of HCV in Blood Donors.Thesis As A Partial Fulfillment For degree of MD , By Khajaee R. Advised By Alavian SM, Tehran, Iran
5-     Liver Biopsy As An Outpatient with coparison with Admision in the Ward .Thesis As A Partial Fulfiiment For degree of MD , By Bahrami N. Advised By Alavian SM,Tehran,Iran
6-     Prevalence of HCV Infection In Hemodialysed Patients.Thesis As A Partial Fulfillment For degree of MD , By Tarami B. Advisad By Alavian SM,Tehran,Iran

 
Books:
1- Alavian SM, Viral Hepatitis For Physicians. Noor-E-Danesh 2002
2- Alavian SM, Hepatitis B, Diagnosis and treatment. Noor-E-Danesh 2002
3- Alavian SM, Concise text of Liver disease and hepatitis in Iran. Noor-E-Danesh 2002
4- Alavian SM, Hepatitis B. Noor-E-Danesh 2001
5- Alavian SM, Hepatitis C. Noor-E-Danesh 2001
6- Alavian SM, Fatty Liver. Noor-E-Danesh 2001
7- Alavian SM, Hepatic Cirrhosis. Liver. Noor-E-Danesh 2001
8- Alavian SM, Treatment of Viral Hepatitis. Noor-E-Danesh 2001
 
Publications:
1- Alavian SM, Raisi F, Abotalebi Z. Intrafamilial transmission of hepatitis virus: in mothers and spouses of hemophiliac patients. Transfusion today (2000)45, 10
2- Alavian SM, Gholami B, Masarrat B. Hepatitis C risk facrtors in Iranian volunteer blood donors:A case-control study. J Gastroenterol hepatol (2002)17, 1092-1097
3- Alavian SM, Doroudi T, Hajarizade B, Hajibigi B. Inrerferon Therapy in Hemophiliac patients with chronic hepatitis C. Transfusion Today 2002(52), 4
4- Alavian SM, Ardeshir A, Hajarizadeh B. Seroprevalence of Anti-Hcv among Iranian Hemophiliac patiens. Transfusion Today (2001)49, 4
5- Alavian Sm, Bakhtiari S, Hajarizadeh B. Transfusion Remains a risk facto for hepatitis C acquisition among patients of hemodialysis. Transfusion Today (2002)50, 4
6- Alavian Sm, Kafaee J, yektaparast B, Hajarizadeh B, Doroudi T. The efficacy of blood donor screening in reducing the incidence of hepatitis C virus infection among thalassemic patients in Iran. Transfusion Today (2003)53,3
7- Alavian SM, Nematizadeh F.Occult HBV infection in patients with serological markers of past HBV infection. AJG April 2003,937
8- Alavian SM, Alavi Moghadam M. Histologic improvement in patients with chronic hepatitis B with proven biochemical effects to lamivudine. BMJ 2001(8), 130
9- Ghavami S et al.A Pilot study on the Role of Alpha 1 Antitrypsin phenotypes in HBV patients. 15th European congress of clinical chemistry and laboratory medicine.
10- Einollahi B et al.Pretransplant hepatitis C virus infection and its effect on the post transplant course of living renal allograft recipient. J gastroenterol hepatol inpress
11- Alavian SM
12- Aalavian SM, Raissi shabari F, Liver profile of Iranian hemophiliacs with hepatitis C. J Gastroenterol hepatol 2000(15) pI209
13- Ebrahimi Daryani N. et al.Prevalence of Transfusion Transmitted Virus in Hepatitis C virus positive hemodialysis patients and its role in ALT increase. Journal of medical faculty 1380(6)  10-15
14- Alavian SM, Kabir A, Hashemi A. Evaluation of interferone-Alfa type 2a (Referon) on patients with chronic hepatitis C. J Iran uni med sci. 1382(33) 61-74
15- Alavian SM, Hatami S. The evaluation of paraclinical situation in patients of chronic hepatitis B after one year treatment with Lamivudine. Govaresh 2002 (37,38) 31-34
16- Einollahi B, Lessan-Pezeshki  M, Khatami MR, Firoozan,A, Aslani  J, Alavian SM, Poorfarzini,V. Incidence of malignancy after renal transplantation. Kowsar Medical Jornal, 2001,6(1),15-20
17- Alavian SM, Kosari F, Einollahi B, Lessan-Pezeshki M, Khatami MR, et al. Liver status in hemodialysis patients with HCV infection seeking renal transplantation. Journal of shahid sadoughi university of Medical Sciences and Health Services, 2001; 9(3): 34-38.
18- Alavian SM, Gholami B.Evolution of Warfield casualties as a risk factor for HVC infection. Teb-E-Nezami 2001;3(4) 183-188
19- Alavian SM, Malekzadeh R, Ghassemian AA, Soleiman nejad H. war field casually, a risk factor for HBV infection in fighters. Teb-e-Nezami 2001;3(1,2) 9-14
20- Fallah hoseini H, Alavian SM. Control and treatment of hepatitis using herbal medicine.giahan-e-daroyee 2001(4) 1-11
21- Alavian SM. Approach to patient with elevated liver enzymes.danesh pezeshki 2001(1);37-40
22- Alavian SM, Shokoohi A. Vitiligo caused by Alfa interferon administration in two patients with chronic hepatitis B. Bimary –haye-poost 2001(5) 45-49
23- Evaluation of liver function in patients under hemodialysis and seeking kidney transplantation. The journal of YUMS 2001(3) 34-38
24- Alavian SM et al. Incidence of HBV and HCV in patients with major thalassemia in Ghazvin district,Iran. Kowsar medical journal 2002;7(4) 319-325
25- Alizadeh AH, Alavian SM, Jafari Kh, Yazdi N. Evaluation of HCVAb, HBsAg and HIV Ab In addicted prisoners of central Yaz jail, Iran. Pajoohesh-dar oloom pezeshki. 2001(4) 311-313
26- Azimi K, Alavian SM et al. Causes of hepatic cirrhosis in hospitalized patients in gastrointestinal ward (of a referral site, Iran) , Sahriati hospital. Govaresh 2001 (37,38) 19-26
27- Hatami S, Alavian SM. Causes and risk factors for viral hepatitis in adult patients referring to Tehran hepatitis Center between years 2000 and 2001. Govaresh 2001 (33,34) 125-130
 
Abstracts (International meetings)
1- Yousefirad M, Malekzadeh R, Khatibian M, Alavian SM, Rezvan H, Kamalian N, Alizadeh BZ. Prospective controlled trial of Interferon alfa-2b in Iranian patients with chronic hepatitis B. 97th Annual meeting of American gastroenterological asiciation. May 11-14, 1997, Washington, D.C
2- Alavian SM, Einollahi B, Khatami MR, Lessan Pezeshki M, Firozan B, Gholami B, Hesseini SM. Liver enzyme levels of patients with chronic renal failure and hepatitis C before and after renal transplantation. 36th congress of the European Renal Association, European Dialysis and Transplant association September 5-8, 1999 Madrid, Spain.
3- Alavian SM, Abolghassemi H, Doroudi T.Interferon therapy in hemophiliac patients with hepatitis C. 26th congress of the International society of blood transfusion. Vienna, Austria, July 9-14, 2000.
4- Alavian SM, Einollahi B, Lessan Pezeshki M, Khatami MR, Firozan A, Nafar M. Fatal fibrosing cholestatic hepatitis in HBV patients following renal transplantation.7th International congress of the middle east society for organ transplantation Lebanon, june 8-11, 2000
5- Alavian SM, Shokoohi A. Vitiligo associated with alpha-interferon 2b in two patients with chronic hepatitis B. 3rd joint meeting of ICS and the ISICR
6- Alavian SM. The prevalence of antibody to hepatitis C virus in renal transplant recipients and their course after transplantation in Iran. World congress of gastroenterology September 6-11, 1998, Vienna, Austria
7- Alavian SM, Raissi Shabari F. Lamivudine for the treatment of chronic hepatitis B non-responsive to interferon alfa. 8th united European gastroenterology week. Brussels,November 25-30, 2000
8- Alavian SM , Einollahi B, Hajarizadeh B .Efficacy and safety of lamivudine on treatment of chronic hepatitis B in renal allogeraft recipients . 8 th International MESOT Congress , Muscat , Sultanate of Oman , 2002;P:132.
9- Einollahi B, Simforoosh N, Hajarizadeh B, Lessan-Pezeshki M , Khatami MR, Noorbala MH, Firoozan A, Pourfarziani V, Poorrezagholi F, Nafar M.Patient and graft outcome after living renal transplantation ; More than 15-year follow up , IRAN . 8 th International MESOT Congress , Muscat , Sultanate of Oman , 2002;P:137
10- Alavian SM , Einollahi B, Hajarizadeh B . Lamivudine in treatment of fibrosing choleststic hepatitis in hepatitis B infected patients following renal transplantation : A case report . 8 th International MESOT Congress , Muscat , Sultanate of Oman , 2002;P:138.
11- Alavian SM, Einollahi B, Shams H,Hamedanizadeh AK, Poorrezagholi F, Hajarizadeh B.Preliminary report of liver histopathologic changes after kidney transplantation. 8 th International MESOT Congress , Muscat , Sultanate of Oman , 2002;P:165.
12- Einollahi B, Hajarizadeh  B, Bakhtiari S, Lessan –Pezeshki M , Alavian SM , Khatami MR, Noorbala MH , Pourfarziani V . Impact of hepatitis C virus infection in patient and graft survival in renal transplant patients . 8 th International MESOT Congress , Muscat , Sultanate of Oman , 2002;P:196.
13- Alavian SM, Sharifi SH, Hajarizadeh B. A comparison between two kits of ELISA test. Evaluation of second generation screening assays for HCV antibodies
14- Daryani NE, Alavian SM, Lessanpezeshki M, hajarizadeh B, Elahian Z. Clinical features of coinfection with TTV in hepatitis C virus infected patients undergoing hemodialysis. 34th congress of the European renal association, European dialysis and transplant association July 14-17, 2002. Copenhagen, Denmark.
15- Einollahi B, Hajarizadeh B, Bakhtiari S, Lessan-Pezeshki M, Khatami MR, Nourbala MH, Pourfarziani V, Alavian SM. SM Pre-Transplant hepatitis C virus infection and its effects on the post-transplant course of living general allografy recipient. 34th congress of the European renal association, European dialysis and transplant association July 14-17, 2002. Copenhagen, Denmark.
 
Abstracts (Domestic seminars)
1- Alavian SM et al.Evaluation of risk factors for hepatitis B infection in blood donors. 7th Iranian congress of internal medicine, Shaheed Beheshti university of medical science, and health services, may 16-19 1996
2- Alavian SM, et al. Hepatitis B, comparison of risk factors between HBS positive and HBS negative blood donors. 10th Iranian congress of internal medicine, may 3-6, 1999
3- Alavian SM. Prevalence of HCV infection in family members of hemophiliac patients with HCV infection. 9th Iranian congress on infectious disease and tropical medicine, 14-18 jan 2001
4- Alavian SM, Saali S.Thalassemia profile with HC infection. 9th Iranian congress on infectious disease and tropical medicine, 14-18 jan 2001
5- Alavian SM, Yadegari D, Alavi Moghadam M.Comparison between Alfa interferon and Lamivudine therapy in patients with chronic hepatitis.  9th Iranian congress on infectious disease and tropical medicine, 14-18 jan 2001
6- Alavian SM, Yadegari D, Alavi Moghadam M.Comparison between Alfa interferon and Lamivudine therapy in patients with chronic hepatitis.  9th Iranian congress on infectious disease and tropical medicine, 14-18 jan 2001
7- Alavian SM, Rasissi Shabari F. hepatic lesions in hemophiliac patients. Seminar for reviewing hepatitis and special disease. 2000
8- Alavian SM, Rasissi Shabari F. hepatic lesions in hemophiliac patients. Seminar for reviewing hepatitis and special disease. 2000
9- Alavian SM, Doroudi T, Einollahi B, Lessan Pezeshki M, Khatami MR, Firozan A, Nafar M, Pourfarziani V, Mahdavi M, khosravi M. Interferon therapy in hemodialyzed hepatitis C patients. 6th Iranian congress of Nephrology Dialysis and Renal transplantation.
10- Alavian SM, Doroudi T.Evaluation of efficacy and side effects of alfa interferon in patients with hepatitis C. 11th Iranian congress of internal medicine, 2000
11- Alavian SM. Hepatic profile of hemophiliac patients with hepatitis C infection. 11th Iranian congress of internal medicine, 2000
12- Alavian SM. Indications and contraindications for hepatic transplantation and patient preparation. 1st Iranian congress on organ transplantation from brain death donors, 2000
13- Alavian SM. New treatments for chronic hepatitis B and C. Re-training seminar on hepatitis, Iran, Karaj 20-21 November 2000
14- Alavian SM. Epidemiology and risk factors of hepatitis C virus in the world and Iran. Re-training seminar on hepatitis, Iran, Karaj 20-21 November 2000
15- Alavian SM. Hepatic cirrhosis and complications. Re-training seminar on gastronintestinal and hepatic desease and pharmacotherapy, Iran, Tehran 1997
16- Alizadeh B et al. Evaluation of Risk factors for chronic hepatitis in multiple clinics in Tehran, Iran. 9th  Iranian congress of internal medicine, May 11-14,1998
17- Alavian SM et al. Determination of risk factors for cirrhosis in hospitalized patients in gastroinstestinal ward of Shariati hospital between 1995 and 1997. 9th Iranian congress of internal medicine, May 11-14, 1998
18- Alavian SM, Einollahi B, Lessan pezeshki M, Khatami MR. Incidence of  HCV infection, routes of transmission and hepatic complications in hemodialyzed and kidney transplanted patients in baghiatollah, Labafinejad and Emam Khomeini hospitals, Tehran Iran.. 9th Iranian congress of internal medicine, May 11-14, 1998
19- Alavian SM. Prognosis before treatment for patients with chronic hepatitis B. 8th Iranian congress on infectious disease and tropical medicine, January 16-20 2000
20- Alavian SM, Saali S. Approach to Hepatitis C. 8th Iranian congress on infectious disease and tropical medicine, January 16-20 2000
21- Alavian SM, Malekzadeh R. Risk factors for hepatitis B infection. 8th Iranian congress on infectious disease and tropical medicine, January 16-20 2000
22- Alavian SM, Ranjbar M.Prevalence of HBV, HCV and HIV infection in addicted prisoners in Hamadan, Iran . 8th Iranian congress on infectious disease and tropical medicine, January 16-20 2000
23- Alavian SM, Ranjbar M, Yazdi N, Jafari K.Prevalence HCV infection in addicted prisoners in Hamadan, Iran . 1st Iranian congress of gastrointestinal and liver disease, Shiraz, Iran 1-4 November 1999
24- Alavian SM, Gholami B. Risk factors of hepatitis C infection; a comparison of prevalence of some possible risk factors between positive and negative blood donors. 1st Iranian congress of gastrointestinal and liver disease, Shiraz, Iran 1-4 November 1999
25- Alavian SM. Hepatic Cirrhosis and complications. Iranian seminar for gastrointestinal and hepatic diseases. Tehran, Iran 1996
26- Alizadeh B, Taheri H et al. Incidence of risk factors for chronic hepatitis in patients of several medical centers in Tehran, Iran. Iranian seminar for gastrointestinal and hepatic diseases. Tehran, Iran 1996
27- Alavian SM et al. Causes for hepatic cirrhosis in hospitalized patients in gastrointestinal ward of Shariati hospital between 1995 and 1997. Iranian seminar for gastrointestinal and hepatic diseases. Tehran, Iran 1996
28- Alavian SM, Einollahi B, Lessan Pezeshki M, Khatami MR. prevalence of HCV infection and its routes of transmission in hemodialysis and kidney transplanted patients, 9th Iranian congress of internal medicine, 11-14 May, 1998
29- Alavian SM ,Saali S. Some cases of misdiagnosis of hepatitis. 8th Iranian congress on infectious disease and tropical medicine. January 16-20, 2000
30- Alavian SM. Pre treatment evaluation of patients with chronic hepatitis B. 8th Iranian congress on infectious disease and tropical medicine. January 16-20, 2000
31- Alavian SM.Approch to patient with hepatitis C. 8th Iranian congress on infectious disease and tropical medicine. January 16-20, 2000
32- Alavian SM, Malekzadeh R. Hepatitis B risk factors,prevalence in blood donors. 8th Iranian congress on infectious disease and tropical medicine. January 16-20, 2000
33- Alavian SM, Ranjbar M.Prevalence of  HBV, HCV and HIV infection in addicted prisoners in Hamadan, Iran. 8th Iranian congress on infectious disease and tropical medicine. January 16-20, 2000
34- Alavian SM, Ranjbar M.Prevalence of  HCV infection in addicted prisoners in Hamadan, Iran. 1st congress on gastrointestinal and liver disease. 1998
35- Alavian SM , Einllahi B, Hajarizadeh B, Nafar M, Ahrabi. Prevalence and risk factors for hepatitis C infection in patients undertaking hemodialysis. 8th Iranian congress on infectious disease and tropical medicine. January 16-20, 2000
36- Hajarizadeh B, Alavian SM, Einollahi B. A case report: Lamivudine efficacy in treatment of fibrosing cholestatic hepatitis in HBV infected patients after renal transplantation. 8th Iranian congress on infectious disease and tropical medicine. January 16-20, 2000
37- Einollahi B, Alavian SM, Bakhtiari S, Nafar M, Hajarizadeh B.Relationshio between pre transplantation dialysis period and hepatitis C infection in renal transplanted patients. 8th Iranian congress on infectious disease and tropical medicine. January 16-20, 2000
38- Alavian SM, Einollahi B, Hajarizadeh B. Efficacy and complications of Lamivudine therapy for treatment of chronic hepatitis B in patients with

39- Alavian SM, Einollahi B,Sadeghi Ghahroodi M.Liver function tests in kidney transplanted patients in Labafijejad hospital, Tehran, Iran. 8th Iranian congress of internal medicine, 1997
40- Taheri H, Malekzadeh, Yousefirad, Alavian SM, Khatibian, Dadras. Causes of chronic hepatitis in Tehran. 7th Iranian congress of internal medicine, 1996
41- Alavi Moghadam M, Yadegari D, Alavian SM.Histologic response to Lamivudine therapy in patients with chronic hepatitis. 8th Iranian congress on infectious disease and tropical medicine. January 16-20, 2000
42- Adibi P et al. Vaccination alone is not effective, HBV transmission from mother to vaccinated child. 8th Iranian congress on infectious disease and tropical medicine. January 16-20, 2000
43- Doroudi T, Alavian SM, Hajibigi S, Nematizadeh F, Hatami S.HCV treatment with Interferon in patients under dialysis before transplantation 8th Iranian congress on infectious disease and tropical medicine. January 16-20, 2000
44- Doroudi T, Alavian SM, Hajibigi B, Nematizadeh F, Hatami S.HCV treatment with Interferon in patients under dialysis before transplantation 8th Iranian congress on infectious disease and tropical medicine. January 16-20, 2000
45- Doroudi T, Alavian SM, Hajibigi B, Nematizadeh F, Hatami S.One year treatment of hemophiliac patients with Interferon. 8th Iranian congress on infectious disease and tropical medicine. January 16-20, 2000
46- Hatami S, Alavian SM, Keshvari M, Hajibigi B, Doroudi T.Incidence of HBV vaccination and related factors in physicians in Tehran. 8th Iranian congress on infectious disease and tropical medicine. January 16-20, 2000
47- Hajarizadeh B, Alavian SM, Saber MM, Hajibigi B. Hepatitis C in hemophiliac patients. 8th Iranian congress on infectious disease and tropical medicine. January 16-20, 2000
48- Hatami S, Alavian SM, Keshvari M, Hajibigi B, Doroudi T.Causes and Risk factors of acute viral hepatitis in adult patients . 8th Iranian congress on infectious disease and tropical medicine. January 16-20, 2000
49- Keshvari M, Alavian SM, Saber MM. evaluation of HBsAg- , HBsAg+ and followup after HBV vaccination. 8th Iranian congress on infectious disease and tropical medicine. January 16-20, 2000
50- Keshvari M, Alavian SM, Hatami S, Saber MM. Efficacy of Lamivudine therapy for one year in patients with chronic hepatitis B. 8th Iranian congress on infectious disease and tropical medicine. January 16-20, 2000
51- Hajarizadeh B, Alavian SM. Hepatitis C in hemophilic patients. Seminar for reviewing of chronic hepatitis, prevention and treatment, 2002
52- Alavian SM. Risk factors for Hepatitis C. Seminar for reviewing of chronic hepatitis, prevention and treatment, 2002
53- Alavian SM. Hepatitis C in veterans with a history of Warfield casualty.The congress of military medicine, Tehran, Iran, October 7-9,  2002
54- Alavian SM, Rajayee M, Arabi M, Saeedi Arab, Emadi VA, Goshtasbi S.Prevalence of HBV and HCV infection in Sepah Pasdaran Enghelab Eslami forces in Tehran district, Iran in 1999. The congress of military medicine, Tehran, Iran, October 7-9,  2002
55- Alavian SM. Epidemiology of Hepatitis C. Seminar for reviewing of viral hepatitis. Tehran, Iran 2000
56- Alavian SM. Epidemiology of Hepatitis B in the world and Iran. Seminar for reviewing of viral hepatitis. Tehran, Iran 2000
57- Alavian SM. Acute viral hepatitis. Seminar for common gastrointestinal disease, 2001
58- Alavian SM. Approach to disturbances in serum aminotransferases, a common finding. Seminar for common gastrointestinal disease, 2001
59- Alavian SM. Virology of hepatitis. 1st Iranian congress on 'From Bed To Bench in gastroenterology & Liver disease' Tehran, Iran.
60- Hatami S, Alavian SM, Doroudi T, Hajibeigi B.The evaluation of paraclinical situation in patients of chronic hepatitis B after one year treatment with Lamivudin. 1st Iranian congress on 'From Bed To Bench in gastroenterology & Liver disease' Tehran, Iran.
61- Ghavami S, Alavian SM et al. Alfa-1 antitripsin phenotype in hepatitis B. 1st Iranian congress on 'From Bed To Bench in gastroenterology & Liver disease' Tehran, Iran.

دفعات مشاهده: 15903 بار   |   دفعات چاپ: 2174 بار   |   دفعات ارسال به دیگران: 362 بار   |   0 نظر
::
مجله طب‌نظامی Journal Mil Med
Persian site map - English site map - Created in 0.06 seconds with 42 queries by YEKTAWEB 3961